Aushon BioSystems Inc. created a scientific advisory board to help advise the company on identifying new markets for its multiplex immunoassay platform.
The Billerica, Mass.-based diagnostic equipment maker named Johann de Bono, John Heymach, Gordon Mills and Gavin MacBeath to the board. MacBeath is the co-founder of Cambridge, Mass.-based Merrimack Pharmaceuticals Inc.
The board will help the company “anticipate key future trends and market opportunities, including the use of multiplex protein biomarkers in companion diagnostics,” Aushon president and CEO Pete Honkanen said in prepared remarks.
